Enable Biosciences Enhances ‘Kit to Clinics’ with Rigorously Vetted ADAP Technology for Diabetes Care

SOUTH SAN FRANCISCO, Calif., Jan. 23, 2024 /PRNewswire/ — Enable Biosciences Inc. is proud to announce the enhancement of its ‘Kit to Clinics’ program for type 1 diabetes care, featuring the ADAP (Antibody Detection by Agglutination-PCR) technology, rigorously and exhaustively vetted…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks